Aptevo Therapeutics Inc. Files S-1/A Amendment
Ticker: APVO · Form: S-1/A · Filed: Mar 25, 2025 · CIK: 1671584
| Field | Detail |
|---|---|
| Company | Aptevo Therapeutics Inc. (APVO) |
| Form Type | S-1/A |
| Filed Date | Mar 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, s-1/a, securities-offering
Related Tickers: APVO
TL;DR
APVO filed an S-1/A, looks like they're still cooking up a securities offering.
AI Summary
Aptevo Therapeutics Inc. filed an S-1/A amendment on March 25, 2025, related to its registration statement. The filing, with registration number 333-285476, pertains to securities offered by the company. Aptevo Therapeutics Inc. is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates ongoing activity related to Aptevo's securities offerings, which could impact investors and the company's capital structure.
Risk Assessment
Risk Level: medium — S-1/A filings often relate to capital raises or significant corporate actions, which carry inherent risks for investors.
Key Numbers
- 2834 — SIC Code (Pharmaceutical Preparations industry)
- 811567056 — EIN (Employer Identification Number)
Key Players & Entities
- Aptevo Therapeutics Inc. (company) — Registrant
- 333-285476 (dollar_amount) — Registration Number
- 20250325 (dollar_amount) — Filing Date
- Marvin L. White (person) — President and Chief Executive Officer
FAQ
What is the purpose of this S-1/A filing?
This is an amendment to a previously filed S-1 registration statement, indicating ongoing efforts related to the registration of securities.
When was this amendment filed?
The filing was made on March 25, 2025.
What is Aptevo Therapeutics Inc.'s primary business sector?
Aptevo Therapeutics Inc. is classified under Pharmaceutical Preparations (SIC code 2834).
Who is the President and CEO of Aptevo Therapeutics Inc.?
Marvin L. White is the President and Chief Executive Officer.
In which state is Aptevo Therapeutics Inc. incorporated?
The company is incorporated in Delaware.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on March 25, 2025 by Marvin L. White regarding Aptevo Therapeutics Inc. (APVO).